Trial NCT04332835
Publication Rojas M, BMC Infect Dis (2022) (published paper)
Primary outcome on the report: (1) Reduction of viral load; (2) Increase in titers of IgG and IgA for SARS-CoV-2 at 28 days of follow up

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.